GenPrime Launches Medical Device in the U.S. Toxicology Market

August 24, 2016

SPOKANE, WA, August 26, 2016 – GenPrime, Inc., a Spokane based biotech company, launched its FDA cleared Point of Care (POC) diagnostic medical device, the POC Reader, in the $1.2B U.S. drug testing market with its partner company, Alere, Inc. based in Waltham, MA.

Read More

GenPrime Receives FDA Clearances

March 04, 2014

SPOKANE, WA, March 4, 2014 – GenPrime, Inc., a downtown-headquartered biotech company, received the first FDA clearances on its software-based medical-device platform, the D-Cipher.

Read More